Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin

被引：60
|
作者：
Ward, PB
Johnson, PDR
Grabsch, EA
Mayall, BC
Grayson, ML
机构：
[1] Austin & Repatriat Med Ctr, Dept Microbiol, Heidelberg, Vic 3084, Australia
[2] Austin & Repatriat Med Ctr, Dept Infect Dis, Heidelberg, Vic 3084, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2001年 / 175卷 / 09期
关键词：
D O I：
10.5694/j.1326-5377.2001.tb143681.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report the first instance in Australia of treatment failure due to a strain of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin - heteroresistant vancomycin-intermediate S. aureus (hVISA). The infection occurred in a 41-year-old man with multiple risk factors. No transmission of the organism to other patients or the environment was detected. This case may herald the beginning of a new phase of staphylococcal resistance in Australia.
引用
收藏
页码：480 / +
页数：5
相关论文
共 50 条
  • [41] Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals
    Cartolano, GL
    Cheron, M
    Benabid, D
    Leneveu, M
    Boisivon, A
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (05) : 448 - 451
  • [42] Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis
    Sipahi, OR
    Arda, B
    Yurtseven, T
    Sipahi, H
    Ozgiray, E
    Suntur, BM
    Ulusoy, S
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (05) : 412 - 415
  • [43] Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA)
    Brown, DFJ
    Edwards, DI
    Hawkey, PM
    Morrison, D
    Ridgway, GL
    Towner, KJ
    Wren, MWD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (06) : 1000 - 1018
  • [44] A Rare Case of Methicillin-Resistant Staphylococcus aureus (MRSA) Enterocolitis Treated With Oral Vancomycin
    Tagliaferri, Ariana R.
    Elagami, Mohamed
    Melki, Gabriel
    Sultana, Yasmeen
    Mechineni, Ashesha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [45] Diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America
    Zurita, Jeannete
    Mejia, Carlos
    Guzman-Blanco, Manuel
    REVISTA CHILENA DE INFECTOLOGIA, 2010, 27 : S70 - S80
  • [46] Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia
    Khosrovaneh, A
    Riederer, K
    Saeed, S
    Tabriz, MS
    Shah, AR
    Hanna, MM
    Sharma, M
    Johnson, LB
    Fakih, MG
    Khatib, R
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) : 1328 - 1330
  • [47] Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections:: Better drug or reduced vancomycin susceptibility?
    Howden, BP
    Charles, PGP
    Johnson, PDR
    Ward, PB
    Grayson, ML
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) : 4816 - 4816
  • [48] Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China
    Hu, Jian
    Ma, Xiao Xue
    Tian, Yuan
    Pang, Long
    Cui, Long Zhu
    Shang, Hong
    PLOS ONE, 2013, 8 (09):
  • [49] Recent Developments in Methicillin-Resistant Staphylococcus aureus (MRSA) Treatment: A Review
    Nandhini, Palanichamy
    Kumar, Pradeep
    Mickymaray, Suresh
    Alothaim, Abdulaziz S.
    Somasundaram, Jayaprakash
    Rajan, Mariappan
    ANTIBIOTICS-BASEL, 2022, 11 (05):
  • [50] Treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in Latin America
    Luna, Carlos M.
    Rodriguez-Noriega, Eduardo
    Bavestrello, Luis
    Gotuzzo, Eduardo
    REVISTA CHILENA DE INFECTOLOGIA, 2010, 27 : S94 - S103
12345